Cargando…
Conditioned medium of mesenchymal stem cells pretreated with H(2)O(2) promotes intestinal mucosal repair in acute experimental colitis
Mesenchymal stem cells (MSCs) are a new therapeutic strategy for inflammatory bowel disease (IBD), and their efficacy has been widely recognized. However, there are still some challenges in cell therapy, including stable cell passage, laboratory conditions for cell culture, high-cost burden, and poo...
Autores principales: | Liu, Peng, Xie, Xiao-ran, Wu, Hao, Li, Huan, Chi, Jing-shu, Liu, Xiao-ming, Luo, Ju, Tang, Yu, Xu, Can-xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715703/ https://www.ncbi.nlm.nih.gov/pubmed/36456585 http://dx.doi.org/10.1038/s41598-022-24493-y |
Ejemplares similares
-
Mechanism of Qingchang Suppository on repairing the intestinal mucosal barrier in ulcerative colitis
por: Shan, Jingyi, et al.
Publicado: (2023) -
Molecular regulation mechanism of intestinal stem cells in mucosal injury and repair in ulcerative colitis
por: Zheng, Lie, et al.
Publicado: (2023) -
Repairing the intestinal mucosal barrier of traditional Chinese medicine for ulcerative colitis: a review
por: Zong, Yichen, et al.
Publicado: (2023) -
Activation of P2Y1R impedes intestinal mucosa repair during colitis
por: Huan, Qiuchan, et al.
Publicado: (2023) -
Anterior Gradient Protein 2 Promotes Mucosal Repair in Pediatric Ulcerative Colitis
por: Ye, Xiaolin, et al.
Publicado: (2021)